APA (7th ed.) Citation

LM, K., ME, W., A, B., BA, G., OM, D., AQ, H., . . . V, M. (2014). Dysregulation of β-catenin is an independent predictor of oncologic outcomes in patients with clear cell renal cell carcinoma. The Journal of urology, 191(6), 1671. https://doi.org/10.1016/j.juro.2013.11.052

Chicago Style (17th ed.) Citation

LM, Krabbe, et al. "Dysregulation of β-catenin Is an Independent Predictor of Oncologic Outcomes in Patients with Clear Cell Renal Cell Carcinoma." The Journal of Urology 191, no. 6 (2014): 1671. https://doi.org/10.1016/j.juro.2013.11.052.

MLA (9th ed.) Citation

LM, Krabbe, et al. "Dysregulation of β-catenin Is an Independent Predictor of Oncologic Outcomes in Patients with Clear Cell Renal Cell Carcinoma." The Journal of Urology, vol. 191, no. 6, 2014, p. 1671, https://doi.org/10.1016/j.juro.2013.11.052.